MoonLake Immunotherapeutics MLTX Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's short-term investments?
- MoonLake Immunotherapeutics (MLTX) reported short-term investments of $59.43M in Q1 2026.
- How has MoonLake Immunotherapeutics's short-term investments changed year-over-year?
- MoonLake Immunotherapeutics's short-term investments decreased by 71.5% year-over-year, from $208.56M to $59.43M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.